These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8520888)

  • 21. A simple alfalfa seedling infection model for Pseudomonas aeruginosa strains associated with cystic fibrosis shows AlgT (sigma-22) and RhlR contribute to pathogenesis.
    Silo-Suh L; Suh SJ; Sokol PA; Ohman DE
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15699-704. PubMed ID: 12426404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucoid conversion by phages of Pseudomonas aeruginosa strains from patients with cystic fibrosis.
    Miller RV; Rubero VJ
    J Clin Microbiol; 1984 May; 19(5):717-9. PubMed ID: 6429192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent infections and immunity in cystic fibrosis.
    Yu H; Head NE
    Front Biosci; 2002 Feb; 7():d442-57. PubMed ID: 11815305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virulence properties of Pseudomonas aeruginosa lacking the extreme-stress sigma factor AlgU (sigmaE).
    Yu H; Boucher JC; Hibler NS; Deretic V
    Infect Immun; 1996 Jul; 64(7):2774-81. PubMed ID: 8698507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microarray analysis reveals induction of lipoprotein genes in mucoid Pseudomonas aeruginosa: implications for inflammation in cystic fibrosis.
    Firoved AM; Ornatowski W; Deretic V
    Infect Immun; 2004 Sep; 72(9):5012-8. PubMed ID: 15321993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections.
    Nguyen D; Singh PK
    Proc Natl Acad Sci U S A; 2006 May; 103(22):8305-6. PubMed ID: 16717189
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular genetics of exopolysaccharide production by mucoid Pseudomonas aeruginosa.
    Ohman DE
    Eur J Clin Microbiol; 1986 Feb; 5(1):6-10. PubMed ID: 3009178
    [No Abstract]   [Full Text] [Related]  

  • 30. Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts.
    Rau MH; Hansen SK; Johansen HK; Thomsen LE; Workman CT; Nielsen KF; Jelsbak L; Høiby N; Yang L; Molin S
    Environ Microbiol; 2010 Jun; 12(6):1643-58. PubMed ID: 20406284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion to mucoidy in Pseudomonas aeruginosa.
    Deretic V; Martin DW; Schurr MJ; Mudd MH; Hibler NS; Curcic R; Boucher JC
    Biotechnology (N Y); 1993 Oct; 11(10):1133-6. PubMed ID: 7764093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane-to-cytosol redistribution of ECF sigma factor AlgU and conversion to mucoidy in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Rowen DW; Deretic V
    Mol Microbiol; 2000 Apr; 36(2):314-27. PubMed ID: 10792719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS; Høiby N; Espersen F; Koch C
    Thorax; 1992 Jan; 47(1):6-13. PubMed ID: 1539148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp.
    Speert DP; Lawton D; Damm S
    J Pediatr; 1982 Aug; 101(2):227-8. PubMed ID: 6808106
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G; Shand GH; Fomsgaard A; Høiby N
    APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global genomic analysis of AlgU (sigma(E))-dependent promoters (sigmulon) in Pseudomonas aeruginosa and implications for inflammatory processes in cystic fibrosis.
    Firoved AM; Boucher JC; Deretic V
    J Bacteriol; 2002 Feb; 184(4):1057-64. PubMed ID: 11807066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis.
    Pier GB; Grout M; Zaidi TS; Goldberg JB
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 2):S175-82. PubMed ID: 8876538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.
    Mowat E; Paterson S; Fothergill JL; Wright EA; Ledson MJ; Walshaw MJ; Brockhurst MA; Winstanley C
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1674-9. PubMed ID: 21297072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.